ArticleJournal of nanobiotechnology2025
Dynamic QSAR modeling for predicting in vivo genotoxicity and inflammation induced by nanoparticles and advanced materials: a time-dose-property/response approach.
Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Data-Driven Engineering of Antimicrobial Nanomaterials for Food Safety and Biomedical Systems.Nanomaterials (Basel, Switzerland) · 2026Review
- Interpretable QSAR models for acute oral toxicity via tuned XGBoost and hybrid data sampling techniques.Scientific reports · 2026Article
- AI-Driven Nano-QSAR Framework for Predicting Carbon Nanotube Cytotoxicity: Overcoming High Dimensionality and Data Imbalance.International journal of nanomedicine · 2026Article
- Harnessing smart nanomaterials to reprogram neutrophil plasticity in immune modulation.Journal of nanobiotechnology · 2025Review
- Nanomedicines for the treatment of genitourinary neoplasms.Materials today. Bio · 2025Review
- Imogolite nanotube modifications impact pulmonary toxicity in mice: implications for safe and sustainable by design (SSbD).Journal of nanobiotechnology · 2025Article
- Bridging the Gap: The Role of Advanced Formulation Strategies in the Clinical Translation of Nanoparticle-Based Drug Delivery Systems.International journal of nanomedicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Predicting the health risks of nanoparticles (NPs) and advanced materials (AdMa) is a critical challenge. Due to the complexity and time-consuming nature of experimental testing, there is a reliance on in silico methods such as quantitative structure-activity relationship (QSAR), which, while effective, often fail to capture the dynamic nature of material activity over time-essential for reliable risk assessment. This study develops dynamic QSAR models using machine learning to predict toxicological responses, such as inflammation and genotoxicity, following pulmonary exposure to 39 AdMa across various post-exposure time points and dose levels. By incorporating exposure time, administered dose, and material properties as independent variables, we successfully developed time-dose-property/response models capable of predicting AdMa-induced in vivo genotoxicity in bronchoalveolar lavage fluid cells, lung and liver tissue, and inflammation in terms of neutrophil influx into the lungs of mice. Key factors driving AdMa-induced toxicity were identified, including exposure dose, post-exposure duration time, aspect ratio, surface area, reactive oxygen species generation, and metal ion release. The time-dose-property/response modeling paradigm presented here provides a practical and robust approach for predicting in vivo genotoxicity and inflammation and supports the comprehensive risk assessment of morphologically diverse AdMa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.